RESUMO
Herbaceous perennial wetland monocots in Northern Ontario, Canada, show dichotomous root overwintering patterns, either with full senescence in autumn or survival over the winter, comparable to deciduous and evergreen leaf habits in trees. To test if these root strategies differ in their associations with growing season length, soil temperatures were recorded in autumn, winter and spring on 38 wetland sites with their dominant species being either of these two root overwintering strategies, altogether 19 monocot species. Traits associated with these strategies were assessed in garden experiments for a subset of these species. Sites with species with autumn-senescing roots were, on average, warmer than sites with species with overwintering roots. The 13 coldest sites were all sites of species with overwintering roots. Spring shoot growth in the field was delayed in species with autumn-senescing roots, despite their higher shoot relative growth rates in the garden, possibly due to the necessity to produce roots first. We conclude that species with autumn-senescing roots are more constrained by temperature than species with overwintering roots, limiting their occurrence in cool climates to locally warm soils and constraining their distribution towards the north. This is comparable to constraints on distribution of deciduous and evergreen trees.
Assuntos
Raízes de Plantas , Solo , Áreas Alagadas , Canadá , Estações do Ano , Temperatura , ÁrvoresRESUMO
BACKGROUND: Factors beyond the individual level such as those characterizing the residential environment may be important to breast cancer outcomes. We provide a systematic review and results of meta-analysis of the published empirical literature on the associations between breast cancer risk and mortality and features of the residential environment. METHODS: Using PRISMA guidelines, we searched four electronic databases and manually searched the references of selected articles for studies that were published before June 2013. We selected English language articles that presented data on adult breast cancer incidence or mortality in relation to at least one area-based residential (ABR) independent variable. RESULTS: We reviewed 31 eligible studies, and observed variations in ABR construct definition and measurement, study design, and analytic approach. The most common ABR measures were indicators of socioeconomic status (SES) (e.g., income, education, summary measures of several SES indicators or composite SES). We observed positive associations between breast cancer incidence and urbanization (Pooled RR for urban vs. rural: 1.09. 95% CI: 1.01, 1.19), ABR income (Pooled RR for highest vs. lowest ABR income: 1.17, 95% CI: 1.15, 1.19) and ABR composite SES (Pooled RR for highest vs. lowest ABR composite SES: 1.25, 95% CI: 1.08, 1.44). We did not observe consistent associations between any ABR measures and breast cancer mortality. CONCLUSIONS: The findings suggest modest positive associations between urbanization and residential area socioeconomic environment and breast cancer incidence. Further studies should address conceptual and methodological gaps in the current publications to enable inference regarding the influence of the residential environment on breast cancer.
Assuntos
Neoplasias da Mama/mortalidade , Classe Social , Meio Social , Adolescente , Adulto , Idoso , Neoplasias da Mama/patologia , Feminino , Humanos , Renda , Pessoa de Meia-IdadeRESUMO
BACKGROUND: Breast cancer patients face several preference-sensitive treatment decisions. Feelings such as regret or having had inadequate information about these decisions can significantly alter patient perceptions of recovery and recurrence. Numerous objective measures of decision quality (e.g., knowledge assessments, values concordance measures) have been developed; there are far fewer measures of subjective decision quality and little consensus regarding how the construct should be assessed. The current study explores the psychometric properties of a new subjective quality decision measure for breast cancer treatment that could be used for other preference sensitive decisions. METHODS: 320 women aged 20-79 diagnosed with AJCC stage 0 - III breast cancer were surveyed at two cancer specialty centers. Decision quality was assessed with single items representing six dimensions: regret, satisfaction, and fit as well as perceived adequacy of information, time, and involvement. Women rated decision quality for their overall treatment experience and surgery, chemotherapy, and radiation decisions separately. Principle components was used to explore factor structure. After scales were formed, internal consistency was computed using Cronbach's alpha. The association of each of the four final scales with patient characteristics scores was examined by Pearson correlation. RESULTS: For overall breast cancer treatment as well as surgery, chemotherapy, and radiation decisions, the six items yielded a single factor solution. Factor loadings of the six decision items were all above .45 across the overall and treatment-specific scales, with the exception of "Right for You" for chemotherapy and radiation. Internal consistency was 0.77, 0.85, 0.82, and 0.78 for the overall, surgery, chemotherapy, and radiation decision quality scales, respectively. CONCLUSIONS: Our measure of subjective appraisal of breast cancer treatment decisions includes 5 related elements; regret and satisfaction as well as perceived adequacy of information, time, and involvement. Future research is needed to establish norms for the measure as is further psychometric testing, particularly to examine how it is associated with outcomes such as quality of life, psychological coping and objective decision quality.
Assuntos
Neoplasias da Mama/psicologia , Informação de Saúde ao Consumidor/normas , Tomada de Decisões , Satisfação do Paciente , Psicometria/instrumentação , Qualidade de Vida/psicologia , Adaptação Psicológica , Adulto , Idoso , Neoplasias da Mama/terapia , Feminino , Georgia , Pesquisas sobre Atenção à Saúde , Humanos , Pessoa de Meia-Idade , Estudos Multicêntricos como Assunto , New York , Participação do Paciente , Psicometria/métodos , Adulto JovemRESUMO
New prognostic tests, such as gene-expression profiling (GEP) of breast tumors, are expected to prolong survival and improve the quality of life for many breast cancer patients. In this article, we argue that GEP has not been adequately validated in minority populations, and that both biological and social factors might affect the broad utility of these tests in diverse populations. We suggest that the widespread use of this technology could potentially lead to suboptimal treatment for black women, resulting in a further increase in black-white patient disparities in treatment response, morbidity and mortality rates. We argue for the need to build a large and diverse evidence base for GEP and other emerging technologies in personalized medicine.